These findings suggest that epigenetic alterations, particularly in CTSZ, contribute to the molecular mechanisms underlying PAH, alongside the limited involvement of established PAH genes like BMP10 [206]. This evidence concerns the gene BMP10 and pulmonary arterial hypertension.